Dogwood Therapeutics, Inc. DWTX
1.28 USD +0.22 (+20.75%)
At closeNov 6, 2026, 7:55 PM EST
1.31 +0.03 +2.34%
After hours · Nov 6, 7:55 PM ET
1.08 Day range 1.37
1.03 52-week range 6.82
- YTD
- -69.23%
- 1 year
- -75.38%
Financial health
Altman Z-Score
2.64 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 5
Valuation
P/E -1.0×
FY 2018 5y median -1.0× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.5×
FY 2018 5y median 0.5× FY 2025
P/FCF -2.2×
FY 2018 5y median -2.2× FY 2025
EV/EBITDA -0.8×
FY 2018 5y median -0.8× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -45.7%
FY 2018 5y median -45.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -45.7%
FY 2018 5y median -110.1% FY 2025
ROIC -32.1%
FY 2018 5y median -107.9% FY 2025
ROA -38.0%
FY 2018 5y median -101.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -128.7%
FY 2018 FY 2025
EPS (diluted) 65.5%
FY 2018 FY 2025
Free Cash Flow -77.7%
FY 2018 FY 2025
Financial Health
Current Ratio 2.8×
FY 2018 5y median 8.0× FY 2025
Quick Ratio 2.8×
FY 2018 5y median 8.0× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2018 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31